CDL and Medical Marijuana: Federal Rules Explained

What CDL Drivers Need to Know About Medical Marijuana

Federal law prohibits commercial driver's license holders from using marijuana, even with a state-issued medical card. Under 49 CFR Part 40, the Department of Transportation's drug and alcohol testing rules apply to every safety-sensitive transportation worker, including CDL drivers regulated by the Federal Motor Carrier Safety Administration. Florida's medical marijuana program does not override that requirement. A Florida medical card does not protect your CDL.

This post exists to answer the question honestly. Miracle Leaf® clinics evaluate roughly 200,000 Florida patients across more than 30 locations, and the most common career-impacting question we receive from working drivers is whether the state card shields them from federal drug testing. The short answer is no. The longer answer covers what happens after a positive test, where the FMCSA Clearinghouse fits in, what CBD risk looks like, and what options exist for drivers whose qualifying conditions push them toward medical cannabis. Career-transition options are below.

Book a Florida evaluation.

For non-CDL household members or after a career transition. Career-transition options below.

How Federal Preemption Works for CDL Drivers

The federal-versus-state question for CDL holders has one answer. Federal law preempts state medical marijuana programs for any worker subject to DOT drug testing. The legal framework comes from 49 CFR Part 40, which establishes uniform procedures for transportation workplace drug and alcohol testing across every DOT modal administration including FMCSA, FAA, FRA, FTA, PHMSA, and USCG.

Cannabis sits on the DOT five-panel drug test. Marijuana, cocaine, opiates, amphetamines, and phencyclidine. A positive marijuana result disqualifies the worker from safety-sensitive duties regardless of where the use occurred. Off-duty use in a legal state still produces a positive test. State medical-card status is not a defense. The Department of Transportation's Office of Drug and Alcohol Policy and Compliance issued a Medical Marijuana Notice confirming this directly. The notice has not been withdrawn.

The DOJ's April 22 2026 rescheduling of marijuana to Schedule III did not change the rule for CDL drivers and cannabis. Rescheduling modified federal tax treatment under IRC section 280E and lowered the procedural barrier for FDA-funded cannabis research. It did not modify 49 CFR Part 40. The FMCSA testing framework that applied on April 21 is the same framework that applies today. For CDL driver medical card cannabis questions, the federal preemption analysis is unchanged.

"Safety-sensitive" under federal rules means any function that affects the safe operation of a commercial motor vehicle. That includes driving, supervising loading, attending the vehicle, and any other duty defined under FMCSA Part 382. CDL drivers and cannabis are not compatible under federal rules, and the framework has been stable since FMCSA promulgated Part 382 in 1995.

The DOT Drug Testing Enforcement Chain

DOT drug testing marijuana enforcement follows a defined sequence. Each step is mandatory and each step generates a record that follows the driver.

1. DOT-mandated pre-employment drug test before any CDL holder enters safety-sensitive duty.
2. Random testing throughout employment at FMCSA-set annual rates for marijuana and other controlled substances.
3. Reasonable-suspicion testing when a trained supervisor observes specific articulable behaviors. Post-accident testing when a fatality, injury requiring medical attention, or disabling vehicle damage occurs.
4. Positive THC result reported to the FMCSA Clearinghouse within two business days of medical review officer verification.
5. Driver removed from safety-sensitive duty pending completion of the return-to-duty process.

A positive test does not produce a single administrative slap. It produces a chain of regulatory consequences that touch every DOT-regulated employer the driver may approach for the next five years.

The FMCSA Clearinghouse

The FMCSA Clearinghouse is a federal database that records every DOT drug and alcohol violation for CDL holders nationally. The registry sits at clearinghouse.fmcsa.dot.gov and went live in January 2020. Every CDL employer regulated by FMCSA must query the Clearinghouse before hiring a driver and must run an annual query for every driver on staff.

What gets recorded. A verified positive drug test. A refusal to test. An actual-knowledge violation reported by an employer. A negative return-to-duty test. A completed return-to-duty process. FMCSA Clearinghouse marijuana records persist for five years from the violation date, then drop off the active query window per the FMCSA Clearinghouse Final Rule.

Drivers may query their own Clearinghouse record for free. Employers query under a consent framework that the driver authorizes through the portal. A pending or unresolved violation flags every prospective employer's query for the full five-year window. The Clearinghouse is the federal mechanism that makes a single positive test follow a driver across state lines and across employers.

DOT Return to Duty After a Marijuana Positive

DOT return to duty marijuana process is set by 49 CFR section 40.301 through section 40.307 and runs through a Substance Abuse Professional. A SAP is a licensed counselor, social worker, physician, or psychologist who meets DOT qualification standards under section 40.281.

The process. The driver locates a qualified SAP using the SAMHSA SAP locator framework. The SAP conducts a face-to-face clinical evaluation. The SAP prescribes a treatment or education program proportionate to the violation. The driver completes the prescribed program. The SAP conducts a follow-up evaluation and determines whether the driver is ready for a return-to-duty test. The employer (or a new employer) administers the directly-observed return-to-duty test. A negative result clears the driver to resume safety-sensitive duty.

Follow-up testing begins after return to duty. Per 49 CFR section 40.307, the SAP prescribes a follow-up testing schedule of at least six unannounced tests in the first 12 months of return to safety-sensitive duty. The schedule may extend up to 60 months at SAP discretion. A second violation during follow-up testing produces another full Clearinghouse cycle.

The return-to-duty window is a no-marijuana window. That includes the state-cardholder period. A driver who holds a Florida medical card and continues medical-cannabis use during follow-up testing will produce a positive result and will re-enter the violation chain. The SAP framework does not recognize medical marijuana CDL license status as a defense to follow-up testing.

CBD Risk for CDL Drivers

CBD CDL drivers face the same federal test panel as any other CDL holder. Cannabidiol products are not on the DOT five-panel test, but THC is. Hemp-derived CBD products sold in retail channels routinely contain measurable THC, sometimes above label-claim concentrations. A driver who consumes CBD in good faith can produce a positive THC test under DOT testing protocols.

Federal rules anticipate this. Under 49 CFR section 40.151, a medical review officer reviewing a positive THC result cannot accept "I did not know the CBD product contained THC" as a valid medical explanation. The 2019 DOT ODAPC notice on CBD risk makes the policy explicit. Drivers are responsible for what they consume and bear the risk of product contamination, mislabeling, and unverified third-party testing.

The practical position for a CDL driver. CBD products are not safe to assume under DOT testing. The product market is not federally regulated for THC content, and DOT enforcement does not recognize good-faith CBD consumption as a defense to a positive test.

Florida CDL Drivers and the OMMU Program

Florida's medical marijuana program operates under Florida Statute section 381.986 and is administered by the Office of Medical Marijuana Use, commonly called OMMU. The OMMU registry is a state credential. It does not shield CDL drivers from DOT testing.

Florida's freight economy is concentrated. Drivers serving the Port of Miami, JAXPORT in Jacksonville, and Port Tampa Bay represent a significant share of Florida CDL employment. The state-versus-federal conflict is concrete for these workers. A Florida medical card and a Florida CDL produce a federal-employment exposure that the state card cannot resolve. The OMMU registry is silent on DOT testing. Federal Motor Carrier Safety Administration drug testing applies to every CDL holder operating in interstate commerce and to most intrastate CDL operations under state-adopted federal rules.

For Florida CDL holders weighing the medical-card decision, the question is not whether the state allows the use. The question is whether DOT testing applies to the position the driver holds.

Practical Options for CDL Drivers and Their Families

Career-transition pathways exist. Drivers whose qualifying conditions push them toward medical cannabis have options that do not require risking the CDL. The most common pathway is a career transition out of safety-sensitive duty into a non-DOT-regulated role. Dispatch, logistics coordination, fleet management, and warehouse supervision are common destinations. None require a DOT drug-testing program.

Once a driver has separated from safety-sensitive duty and the Clearinghouse five-year window has closed (or for a driver who never held a CDL), the Florida medical-card pathway opens. Miracle Leaf® clinics evaluate the qualifying condition against section 381.986 and submit the certification to the OMMU registry. The four-step OMMU process applies. The state fee is $77.75 per year.

For non-CDL household members of CDL drivers, the path is unchanged. A spouse, adult child, or parent of a CDL driver may apply for a Florida medical card without affecting the driver's CDL status. The Clearinghouse records the driver, not the household. Florida clinics serving CDL-driver families include Jacksonville San Marco, Miami Wynwood, and West Palm Beach.

The honest framing for working drivers: a medical card is not a workaround. It is a credential for non-DOT-regulated patients. Drivers who want the option without the federal exposure plan the career transition first and the medical evaluation second.

Not driving a CDL? Book a Florida evaluation to find out if you qualify.

Telehealth and Renewals for Florida Patients

Driving long-haul or stationed out of state for work? Returning Florida patients may renew via telehealth once the initial in-clinic relationship is established under section 381.986. Telehealth visits are available for renewals across most states with medical cannabis programs. The renewal pathway is real for non-CDL Florida patients who travel for work.

For CDL drivers the calculation does not change. A Florida CDL is still preempted under DOT rules whether the certification was issued in clinic or via telehealth. No certification, telehealth or in person, shields a CDL holder from federal drug testing requirements. The telehealth pathway is a convenience feature for non-CDL renewals. It is not a workaround for federal preemption.

State-by-State CDL and Medical Marijuana Status

Federal preemption applies in every state. The DOT testing framework is uniform under 49 CFR Part 40. State medical-program details vary, but no state program shields a CDL holder from FMCSA drug testing. A grid summarizing each state medical program's interaction with CDL holders is in development and will hydrate from per-state data once the schema lands. The federal answer does not vary by state.

If you hold a Florida CDL, see the OMMU section above. If you hold a CDL issued by another state and operate in Florida freight corridors, the federal preemption analysis is the same and the OMMU program offers no exemption.

Sources for CDL and Medical Marijuana

• 49 CFR Part 40, Procedures for Transportation Workplace Drug and Alcohol Testing Programs. Federal .gov primary regulation.
• 49 CFR section 40.151, Medical Review Officer review of positive THC results. Federal .gov primary regulation.
• 49 CFR section 40.307, Substance Abuse Professional follow-up testing schedule. Federal .gov primary regulation.
• FMCSA Part 382, Controlled Substances and Alcohol Use and Testing for CDL holders. Federal .gov primary regulation.
• FMCSA Clearinghouse, federal CDL violation registry. Federal .gov program portal.
• DOT ODAPC Medical Marijuana Notice, official policy clarification. Federal .gov enforcement guidance.
• SAMHSA Substance Abuse Professional, program framework for DOT-mandated SAP evaluations. Federal .gov clinical authority.
• Florida Statute section 381.986, Medical use of marijuana. State .gov primary statute.
• Florida Office of Medical Marijuana Use, OMMU program portal. State .gov program portal.

Related CDL and Medical Marijuana Resources

• Florida program details for the OMMU registry and section 381.986 framework.
• How to get a medical marijuana card online for the standard Florida pathway.
• Qualifying conditions for the complete Florida list under section 381.986.

Career Transition or Family Evaluation Options

Career-transition consultation or family-member evaluation? Find the nearest Jacksonville San Marco, Miami Wynwood, or West Palm Beach clinic, or call (833) LEGAL-MJ.

Disclaimer

This post is informational and is not medical or legal advice. Federal CDL testing rules are set by 49 CFR Part 40 and administered by the Department of Transportation and the Federal Motor Carrier Safety Administration. Florida's medical marijuana program is set by section 381.986 and administered by OMMU. Cannabis remains a Schedule III controlled substance under federal law as of the April 22 2026 DOJ rescheduling order. A state medical card does not protect federal employment, federal contracting, or DOT-regulated transportation work. Consult a qualified attorney with federal-employment or DOT-regulatory expertise for legal questions specific to your CDL situation.